Shares of Digirad Co. (NASDAQ:DRAD) passed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $3.67 and traded as low as $4.05. Digirad shares last traded at $4.05, with a volume of 1,074 shares changing hands.
Separately, ValuEngine upgraded Digirad from a “hold” rating to a “buy” rating in a report on Thursday, October 3rd.
The company has a quick ratio of 1.03, a current ratio of 1.42 and a debt-to-equity ratio of 0.77. The stock has a fifty day moving average price of $4.63 and a two-hundred day moving average price of $3.70.
Digirad (NASDAQ:DRAD) last posted its earnings results on Tuesday, August 6th. The medical equipment provider reported $0.04 earnings per share for the quarter. Digirad had a negative return on equity of 10.97% and a negative net margin of 5.81%. The company had revenue of $25.80 million for the quarter.
In related news, Director Jeffrey E. Eberwein bought 300,000 shares of the company’s stock in a transaction dated Tuesday, September 10th. The shares were bought at an average price of $10.00 per share, for a total transaction of $3,000,000.00. Following the completion of the acquisition, the director now directly owns 4,419 shares of the company’s stock, valued at $44,190. The acquisition was disclosed in a document filed with the SEC, which is available at this hyperlink. 7.30% of the stock is owned by company insiders.
A hedge fund recently bought a new stake in Digirad stock. Dalton Greiner Hartman Maher & Co. purchased a new stake in shares of Digirad Co. (NASDAQ:DRAD) in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm purchased 16,564 shares of the medical equipment provider’s stock, valued at approximately $74,000. Dalton Greiner Hartman Maher & Co. owned about 0.81% of Digirad at the end of the most recent quarter. Hedge funds and other institutional investors own 38.18% of the company’s stock.
About Digirad (NASDAQ:DRAD)
Digirad Corporation provides healthcare solutions in the United States and internationally. It operates through three segments: Diagnostic Services, Mobile Healthcare, and Diagnostic Imaging. The Diagnostic Services segment provides nuclear and ultrasound imaging services to physicians who perform nuclear imaging, echocardiography, vascular or general ultrasound tests, imaging systems, radiopharmaceuticals, and licensing services.
Featured Article: Monthly Dividend Stocks
Receive News & Ratings for Digirad Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Digirad and related companies with MarketBeat.com's FREE daily email newsletter.